Occurrence of Pulmonary Oil Microembolism After Testosterone Undecanoate Injection: A Postmarketing Safety Analysis

Occurrence of Pulmonary Oil Microembolism After Testosterone Undecanoate Injection: A Postmarketing Safety Analysis

Background: The Aveed Risk Evaluation and Mitigation Strategy program was instituted because of potential risk of pulmonary oil microembolism (POME) and/or anaphylaxis after intramuscular injection of Aveed (testosterone undecanoate), indicated for treatment of adult male patients with congenital or...

Full description

Bibliographic Details
Main Authors:	Alexander W. Pastuszak, MD, PhD, Yiqun Hu, MD, PhD, Jeffrey D. Freid, MD
Format:	Article
Language:	English
Published:	Oxford University Press 2020-06-01
Series:	Sexual Medicine
Subjects:	Cough Hypogonadism Product Surveillance Pulmonary Embolism Safety Testosterone
Online Access:	http://www.sciencedirect.com/science/article/pii/S2050116120300234

Similar Items

Safety Aspects and Rational Use of Testosterone Undecanoate in the Treatment of Testosterone Deficiency: Clinical Insights
by: Campbell K, et al.
Published: (2023-03-01)

Optimal injection interval for testosterone undecanoate treatment of hypogonadal and transgender men
by: Nandini Shankara Narayana, et al.
Published: (2021-07-01)

The HEAT-Registry (HEmatopoietic Affection by Testosterone): comparison of a transdermal gel vs long-acting intramuscular testosterone undecanoate in hypogonadal men
by: Michael Zitzmann, et al.
Published: (2022-12-01)

Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men
Published: (2012-12-01)

Effects of the oral testosterone undecanoate Kyzatrex™ on ambulatory blood pressure in hypogonadal men
by: William B. White, et al.
Published: (2021-07-01)

Patient Satisfaction with Oral Testosterone Undecanoate in Men Who Received Prior Testosterone Therapy: An Open-Label, Single- Center Clinical Trial
by: Marco-Jose Rivero, et al.
Published: (2024-10-01)

Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men
Published: (2013-03-01)

Effect of testosterone undecanoate on sexual functions, glycaemic parameters, and cardiovascular risk factors in hpogonadal men with type 2 diabetes mellitus
by: Ronak Gandhi, et al.
Published: (2022-01-01)

Endogenous testosterone and mortality risk
by: Emily J Meyer, et al.
Published: (2018-01-01)

Controversies in testosterone replacement therapy: testosterone and cardiovascular disease
by: Kathleen Hwang, et al.
Published: (2015-04-01)

Impact of testosterone levels and testosterone replacement ther-apy on men’s health
by: Zuzanna Karbowska, et al.
Published: (2023-12-01)

Testosterone undecanoate supplementation together with human chorionic gonadotropin does not impair spermatogenesis in males with isolated hypogonadotropic hypogonadism: a retrospective study
by: Yin-Wei Chen, et al.
Published: (2019-01-01)

Testosterone deficiency and chronic kidney disease
by: Michael Zitzmann
Published: (2024-09-01)

Comparison of the Effects of Testosterone Gels, Injections, and Pellets on Serum Hormones, Erythrocytosis, Lipids, and Prostate‐Specific Antigen
by: Alexander W. Pastuszak, MD, PhD, et al.
Published: (2015-09-01)

Effect of a Combination of Omega-3 and Oral Testosterone Undecanoate On Serum Testosterone Levels in Patients with Testosterone Deficiency
by: Min Gu Park, et al.
Published: (2020-06-01)

Male hypogonadism (part 2)
by: Ye.V. Luchytskyy, et al.
Published: (2017-08-01)

Depression in men with testosterone deficiency (Preliminary results of the study)
by: Y. Osadshiy, et al.
Published: (2022-06-01)

Association of subcutaneous testosterone pellet therapy with developing secondary polycythemia
by: Katherine Lang Rotker, et al.
Published: (2018-01-01)

Cognitive effects of testosterone and finasteride administration in older hypogonadal men
by: Borst SE, et al.
Published: (2014-08-01)

Testosterone levels in men with chronic migraine
by: Lisa B.E. Shields, et al.
Published: (2019-06-01)

Application of Transdermal Testosterone in Treatment of Male Hypogonadism
by: Mahgol Tajbakhsh, et al.
Published: (2018-10-01)

Usefulness of routine assessment of free testosterone for the diagnosis of functional male hypogonadism
by: Paolo Facondo, et al.
Published: (2022-12-01)

Safety and efficacy of testosterone gel in the treatment of male hypogonadism
by: Kishore M Lakshman, et al.
Published: (2009-10-01)

Human Chorionic Gonadotropin monotherapy for the treatment of hypogonadal symptoms in men with total testosterone > 300 ng/dL
by: Vinayak Madhusoodanan, et al.
Published: (2019-11-01)

The Role of Testosterone in Spermatogenesis: Lessons From Proteome Profiling of Human Spermatozoa in Testosterone Deficiency
by: Giuseppe Grande, et al.
Published: (2022-05-01)

The complex relation between obstructive sleep apnoea syndrome, hypogonadism and testosterone replacement therapy
by: Andrea Graziani, et al.
Published: (2023-10-01)

The British Society for Sexual Medicine Guidelines on Male Adult Testosterone Deficiency, with Statements for Practice
by: Geoffrey Hackett, et al.
Published: (2023-07-01)

Management of Male Fertility in Hypogonadal Patients on Testosterone Replacement Therapy
by: Julius Fink, et al.
Published: (2024-02-01)

Diagnosis and management of testosterone deficiency
by: James A McBride, et al.
Published: (2015-04-01)

Study of testosterone as a predictor of tumor aggressiveness in patients with prostate cancer
by: Pedro Henrique Oliveira Cabral, et al.
Published: (2013-04-01)

Short-Acting Testosterone: More Physiologic?
by: Gerwin Westfield, et al.
Published: (2020-09-01)

Risks of testosterone replacement therapy in men
by: E Charles Osterberg, et al.
Published: (2014-01-01)

Compliance with Testosterone Replacement Therapy in Patients with Testosterone Deficiency Syndrome: A 10-Year Observational Study in Korea
by: Byeongjin Kang, et al.
Published: (2022-10-01)

Decreased serum testosterone level was not significantly correlated with lipid indices in elderly men
by: Neda Meftah, et al.
Published: (2021-03-01)

Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return?
by: Abdulmaged Traish
Published: (2016-11-01)

Relationship Between Serum Testosterone and Severity of Lower Urinary Tract Symptoms Among Malaysian Men
by: Suzliza Shukor, et al.
Published: (2022-09-01)

Clinical and pharmacological basis of the use of testosterone drugs for hormonal replacement therapy for hypogonadism in men
by: N. I. Volkova, et al.
Published: (2022-09-01)

Testosterone treatment in the aging male: myth or reality?
by: Nicole Nigro, et al.
Published: (2012-03-01)

Guidelines for the Diagnosis and Treatment of testosterone deficiency (hypogonadism) in male patients with diabetes mellitus
by: Ivan I. Dedov, et al.
Published: (2017-12-01)

Shifting the Paradigm of Testosterone Replacement Therapy in Prostate Cancer
by: Michael A. Bell, et al.
Published: (2018-05-01)